Items where authors include "Hadji, P."

Article

Moon, R.J. orcid.org/0000-0003-2334-2284, Reginster, J.-Y. orcid.org/0000-0001-6290-752X, Al-Daghri, N.M. orcid.org/0000-0001-5472-1725 et al. (26 more authors) (2023) Real-world evidence: new opportunities for osteoporosis research. Recommendations from a working group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis International, 34. pp. 1283-1299. ISSN 0937-941X

McCloskey, E. orcid.org/0000-0003-0177-8140, Rathi, J., Heijmans, S. et al. (9 more authors) (2022) Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe. Archives of Osteoporosis, 17 (1). 20. ISSN 1862-3522

Brown, J.E. orcid.org/0000-0003-4960-3032, Wood, S.L., Confavreux, C. et al. (13 more authors) (2021) Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic : an international perspective and recommendations. Journal of Bone Oncology, 29. 100375. ISSN 2212-1374

McCloskey, E. orcid.org/0000-0003-0177-8140, Rathi, J., Heijmans, S. et al. (9 more authors) (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care : a multi-country cross-sectional observational study. Osteoporosis International, 32 (2). pp. 251-259. ISSN 0937-941X

Pepe, J., Body, J.-J., Hadji, P. et al. (8 more authors) (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. The Journal of Clinical Endocrinology & Metabolism, 105 (8). pp. 2487-2506. ISSN 0021-972X

Kanis, J.A., Cooper, C., Rizzoli, R. et al. (16 more authors) (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporosis International, 28 (7). pp. 2023-2034. ISSN 0937-941X

Hadji, P., Aapro, M.S., Body, J-J. et al. (18 more authors) (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology, 7. pp. 1-12. ISSN 2212-1374

Cummings, S.R., Cosman, F., Lewiecki, E.M. et al. (17 more authors) (2017) Goal-Directed Treatment for Osteoporosis: A Progress Report from the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. Journal of Bone and Mineral Research, 32 (1). pp. 3-10. ISSN 0884-0431

Hadji, P., Coleman, R. orcid.org/0000-0002-4275-1043, Gnant, M. et al. (1 more author) (2012) The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis. Annals of Oncology, 23 (11). pp. 2782-2790. ISSN 0923-7534

Coleman, R. orcid.org/0000-0002-4275-1043 and Hadji, P. (2012) Bone Oncology-An emerging multi-disciplinary specialty. Journal of Bone Oncology, 1 (1). p. 1. ISSN 2212-1366

Coleman, R.E. orcid.org/0000-0002-4275-1043, Lipton, A., Roodman, G.D. et al. (11 more authors) (2010) Metastasis and bone loss: Advancing treatment and prevention. Cancer Treatment Reviews, 36 (8). pp. 615-620. ISSN 0305-7372